RECENT NEWS

Visit the WFH News page to find out more about the events and developments that are making a difference today.

14th WFH Global Forum explores advances and access in bleeding disorders care

14th WFH Global Forum explores advances and access in bleeding disorders care

The 14th World Federation of Hemophilia (WFH) Global Forum took place in Montreal, Canada, on November 13 to 14, 2025, bringing together healthcare professionals, patient advocates, policymakers, and industry leaders from around the world. Under the theme of advances and access to safe treatment products for bleeding disorders, the WFH Global Forum sparked dynamic discussions on the latest scientific developments and the challenges of equitable care.

Also available in: Français Español

Day 1 of the WFH Global Forum focused on the need for continuous vigilance and adaptation in pathogen safety, addressing biases and gaps in women’s care, and complexities in diagnosis and treating von Willebrand disease (VWD). Sessions also explored recently approved rebalancing agents as well as global availability of treatment products.

Day 2 opened with an inspiring keynote presentation by WFH Board of Directors Medical Member, Cedric Hermans, MD, on the growing impact of artificial intelligence (AI) on hemophilia care. Hermans discussed AI’s potential for enabling personalized treatment, improving education, optimizing clinical practice, and driving therapeutic innovation. Subsequent sessions focused on the impact of different WFH programs on clinical care in countries, the evolving gene therapy landscape, and the innovative treatments and technologies on the horizon.

The WFH Global Forum offered a unique opportunity for participants to assess the current state of care for all people with bleeding disorders, explore future therapeutic options, share experiences, and discuss innovative strategies to improve access worldwide—reaffirming the community’s commitment to advancing treatment and ensuring safe, sustainable care for everyone.

To learn more about the 14th WFH Global Forum, click here.

The 14th edition of the WFH Global Forum was supported by funding from: CSL, Pfizer, Sanofi, and Sobi; with additional support from: Biomarin.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.